PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?
Visit https://www.peervoice.com/SZV860 to view the entire programme with slides. After completing “Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?”, participants will be able to: Recall the molecular and pathological mechanisms of HER3 that make it a promising therapeutic target in non-small cell lung cancer (NSCLC) and breast cancer; and Assess the clinical relevance of safety and efficacy data from randomised clinical trials evaluating HER3-targeted agents.